The unmet need in the elderly: How immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines
- 9 March 2012
- journal article
- review article
- Published by Elsevier BV in Vaccine
- Vol. 30 (12), 2060-2067
- https://doi.org/10.1016/j.vaccine.2012.01.015
Abstract
No abstract availableFunding Information
- National Institutes of Health
- Bundesministerium für Bildung und Forschung (0315890F)
- National Institute of Allergy and Infectious Diseases
- Seventh Framework Programme (259679)
- Canadian Institutes of Health Research (R01 AI68265, U01 AI074449)
- European Commission
- Deutsche Forschungsgemeinschaft (PA 361/14-1)
This publication has 101 references indexed in Scilit:
- Granzyme B-Dependent Proteolysis Acts as a Switch to Enhance the Proinflammatory Activity of IL-1αMolecular Cell, 2011
- Inflammatory markers in population studies of agingAgeing Research Reviews, 2011
- Age effects on B cells and humoral immunity in humansAgeing Research Reviews, 2011
- Relationship between functional ability in older people, immune system status, and intensity of response to CMVAGE, 2011
- Age-related changes in memory and effector T cells responding to influenza A/H3N2 and pandemic A/H1N1 strains in humansVaccine, 2011
- Clinical and immunologic predictors of influenza illness among vaccinated older adultsVaccine, 2010
- Influenza-Induced Production of Interferon-Alpha is Defective in Geriatric IndividualsJournal of Clinical Immunology, 2010
- Immunosenescence: what does it mean to health outcomes in older adults?Current Opinion in Immunology, 2009
- Lower GrB+ CD62Lhigh CD8 TCM effector lymphocyte response to influenza virus in older adults is associated with increased CD28null CD8 T lymphocytesMechanisms of Ageing and Development, 2007
- Influenza-Associated Hospitalizations in the United StatesJAMA, 2004